DIFFUSION PHARMACEUTICALS IN (DFFN) Stock Cash Flow
NASDAQ:DFFN - Nasdaq - US2537484048 - Common Stock - Currency: USD
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -13.08M | -15.59M | -24.10M | -14.19M | -11.80M | |||
| Depreciation Amortization | N/A | 0.00 | 93.42K | 103.17K | 100.00K | |||
| Income Taxes - Deferred | N/A | 0.00 | -443.89K | -1.68M | 330.00K | |||
| Change In Working Capital | -1.10M | -97.16K | 356.37K | 1.47M | 990.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 335.01K | 719.48K | 9.59M | 736.12K | 520.00K | |||
| OPERATING CASH FLOW | -13.85M | -14.97M | -14.50M | -13.55M | -9.86M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| Other Investing Activity | 22.88M | -12.24M | 4.00K | N/A | N/A | |||
| INVESTING CASH FLOW | 22.88M | -12.24M | 4.00K | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 0.00 | 5.00K | 33.30M | 18.87M | 16.21M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -982.33K | -160.00K | |||
| FINANCING CASH FLOW | 0.00 | 5.00K | 33.30M | 17.89M | 16.04M | |||
| CHANGE IN CASH | 9.03M | -27.20M | 18.80M | 4.34M | 6.19M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.85M | -14.97M | -14.50M | -13.55M | -9.86M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | -13.85M | -14.97M | -14.50M | -13.55M | -9.86M | |||
All data in USD